Skip to content

Dose-effect relationship of acupunctrue point Hegu(LI4) on treating central facial paralysis and its influence on the specific skin area

Dose-effect relationship of acupunctrue point Hegu(LI4) on treating central facial paralysis and its influence on the specific skin area

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002745
Enrollment
Unknown
Registered
2012-12-04
Start date
2012-07-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central facial paralysis

Interventions

A:direct puncture 5 seconds
B:Oblique needling 5 seconds
C:direct puncture 30 seconds
D:Oblique needling 30 seconds

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who accord with the diagnosis standard of cerebral infarction and central facial palsy; (2) Patients who accept the acupuncture treatment voluntarily; (3) Patients who have signed the informed consent form of clinical trial; (4) first onset; (5) Aged 40 to 80; (6) disease course=5, <=20.

Exclusion criteria

Exclusion criteria: 1. Patients with preexisting stroke and leave behind facial paralysis; 2. Patients with transient ischemic attack (TIA), peripheral facial paralysisasymmetric in face muscle, subarachnoid hemorrhagepostoperation of cerebral hemorrhageand with the experience of thrombolytic therapy; 3. Patients with serious disturbance of consciousness, or combined with serious primary disease and complications of cardiovascular, liver, kidney and hematopoietic system, such as heart failure, renal failure, cancer, and other disease or condition which have more affects on patientss quality of life; 4. Patients with history of mental illness, dementia, aphasia and cognitive dysfunction, as well as who can not express their opinion; 5. Skin disease patients (upper limbs, facial and abdominal) or infection fever may affect the detection of infrared camera and laser doppler; 6. Patients are suspected with history of alcohol, drug abuse, or according to the judgmet, they with other medical history, which will make the research complex, such as high frequently change of job which may cause case lose, and who without well compliance; 7. Patients are simultaneous participating in other clinical research.

Design outcomes

Primary

MeasureTime frame
Facial paralysis evaluation scale;Infrared thermal images;Blood flow;

Countries

China

Contacts

Public ContactMeng Zhihong
yj1988mzh@163.com+86 18722699933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026